Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer - Wikidata - wikimedia - TriplyDB

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

http://www.wikidata.org/entity/Q28245761

about

Galectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell line Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux Cancer Therapy Due to Apoptosis: Galectin-9.Carbohydrate-recognition domains of galectin-9 are involved in intermolecular interaction with galectin-9 itself and other members of the galectin family.Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.Galectin-9: Diverse roles in hepatic immune homeostasis and inflammation.Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.Synthesis and biological evaluation of a library of glycoporphyrin compounds.TIM-3 as a therapeutic target in human inflammatory diseases.Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection Galectin-9 is Involved in Immunosuppression Mediated by Human Bone Marrow-derived Clonal Mesenchymal Stem Cells.Abnormal expression of Tim-3 antigen on peripheral blood T cells is associated with progressive disease in osteosarcoma patients.CCBE1 promotes GIST development through enhancing angiogenesis and mediating resistance to imatinib.Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma.Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.Galectins as cancer biomarkers.Galectins in cancer: carcinogenesis, diagnosis and therapy.The bitter side of sweet: the role of Galectin-9 in immunopathogenesis of viral infections.Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer.Galectin-9: From cell biology to complex disease dynamics.Peroxisome proliferator-activated receptor γ upregulates galectin-9 and predicts prognosis in intestinal-type gastric cancer.Galectin-9 protein expression in endothelial cells is positively regulated by histone deacetylase 3.Molecular characterization of T-cell immunoglobulin mucin domain-3 and Galectin-9 genes of swamp- and riverine-type water buffaloes.Involvement of Galectin-3 with vascular cell adhesion molecule-1 in growth regulation of mouse BALB/3T3 cells.The glycan-binding protein galectin-9 has direct apoptotic activity toward melanoma cells.Anguilla japonica lectin 1 delivery through adenovirus vector induces apoptotic cancer cell death through interaction with PRMT5.Role of galectins in lung cancer.Role of Galectins in Tumors and in Clinical Immunotherapy.Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9.Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.T-cell immunoglobulin and mucin domain-containing protein-3 and galectin-9 protein expression: Potential prognostic significance in esophageal squamous cell carcinoma for Chinese patients.MicroRNA profiles during galectin-9-induced apoptosis of pancreatic cancer cells.Pattern of galectins expression in actinic cheilitis with different risks of malignant transformation.

P2860

Q24323267-DA0839CB-C837-404E-80B4-4DB32F786C55 Q28081459-27ACA406-2438-4B23-8DD7-FAF370A4D1A6 Q28607006-91A2FDAB-1FFA-4065-81D0-BB1010E70263 Q30397015-EF138D8A-63EF-49D8-BD42-5C28F99103DE Q33269241-302BF87B-3449-45DB-9B1F-453530204D7E Q33828349-800DB840-1761-4708-9031-C510D47C8D81 Q33923368-034C97E7-C258-494C-90A9-F338E8B30B11 Q34258192-0B83434A-B1EC-40A2-AE79-8D53C65F8364 Q34423462-F7C8232F-6E30-4230-B393-5D320E1BEB6F Q34657914-268C2DBD-7073-4006-9503-692590F97D27 Q34997704-5E339B19-851C-4A96-8DF5-770242DAC032 Q35067641-B6E2149B-FD60-43A8-A4BD-9B30307CE7B5 Q35661292-5E42420A-D967-4559-83FE-35102CD78B08 Q35974260-908C306B-622B-4A72-8E80-F1A8552F5D82 Q35986628-E7642EB2-A35E-42B1-B3E4-F0D6A522929D Q36260708-A2679347-720C-4D84-A67A-C80ADB283B47 Q37148793-6ECC92FD-F7CF-40DF-A3D5-D6BD0530413D Q37163261-186A05CC-FE05-4274-B320-930BA53D160F Q37277241-5EBEBDFA-8A63-49D4-9DA7-DA4E4491E57A Q37705021-E6A32BF2-09C7-4A20-8159-568ECE3DE014 Q38019412-21307E54-13FF-46EC-AE09-07520699DD01 Q38105320-C5727896-5D14-4C79-B226-AF2F34456111 Q38269048-9A2DD421-5752-440A-839E-70BC31C5970B Q38373689-0AC1ADB0-0716-404F-9192-875AA7B9C84E Q38636569-5A4864D9-08BD-443A-BAB6-1FB7CD02FEC1 Q38687867-B1A5F4E6-DD06-40A5-8CD0-DF6777B7C31F Q38942909-2221E712-67ED-4F55-A6CD-177982089AF9 Q38979843-12A48B86-C1B4-407E-B5F8-3D072E1B8722 Q39936454-5EA9E2AB-41C0-460C-9F02-9EFB777C4ADE Q40461629-8AE5EF17-3A5E-4AD4-9090-EABAAD1A5E1C Q42832722-EF3A309C-5032-46DD-8144-DA4831D7D63A Q43244358-BCE394B9-01C8-4465-8FD2-FBB33A7F4212 Q45884221-08A7B1C5-2700-47D4-9364-1477B41245B5 Q47108427-7465EF8C-6FFE-4187-8D97-3C6234C20EE1 Q48124343-291BF144-D53D-4A64-B7B9-FC4095C1BF83 Q48182229-8FFD5D57-0329-42E5-84EF-EB55D1767BE9 Q48270428-E99464D7-2AD1-4D23-AE2A-871554866628 Q49986075-8E9B17ED-05EB-4FB6-B2AF-BDF5DBFE6068 Q50224538-107FA736-4B24-44BE-B5B7-1E2EA3952227 Q53208686-4C390C04-0AD1-4ED1-B23D-F8B73716846F

P2860

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

http://www.wikidata.org/entity/Q28245761

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

@ast

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

@en

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

@nl

type

label

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

@ast

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

@en

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

@nl

prefLabel

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

@ast

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

@en

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

@nl

P1433

Q28245761-746A2916-78C9-4ABD-815D-8B9647485EB2

P1476

Q28245761-6A850C76-4138-40C8-964B-C73931FA680C

P2093

Q28245761-0388A9C5-099A-4FE7-A301-0AE1FCDCD29F

Q28245761-11AAC901-C065-482D-AD56-4741DC073932

Q28245761-20793045-EDBB-4B4F-90D0-C0917C6B35B6

Q28245761-29044EF6-6A85-4F26-9BCD-09E5B539279F

Q28245761-407EE87D-A5FC-46E0-9D37-6EC51440DB66

Q28245761-48D533BB-D3A2-4203-BE26-7ABF3F646FB2

Q28245761-8C86D04A-749D-40F1-8791-D284DEC58803

Q28245761-AF6AFE2F-6238-4A1D-87C7-00EF6622DD5A

Q28245761-DA06CF38-5217-43CC-BFAC-53C6B5E9477E

Q28245761-EAF31F67-AA25-4679-88F2-F4577DBBA5E8

P304

Q28245761-11FE2E9E-E84A-4332-B90C-7FA4DC0ADFE0

P31

Q28245761-8C83762C-5C65-4F69-9A18-07279C20EB9B

P3181

Q28245761-D733DE93-7706-4B74-9F0A-A26CDDB2B559

P356

Q28245761-5D196BC8-F7C1-4EB1-A57A-633E738DE671

P407

Q28245761-F3C03756-64DE-4F0D-A3DA-E57DF482178F

P433

Q28245761-B475B1DC-4EF2-405D-992D-54F2D7F8930E

P478

Q28245761-826C2DC8-8259-43BD-BB8F-EB194327DCD0

P577

Q28245761-6F3FCDA3-4AFA-4898-B8AC-2464AA61C14A

P698

Q28245761-6F2C8AE4-2163-4CEB-8DFD-94B785E26991

P3181

P356

1078-0432.CCR-04-0861

P1433

Clinical Cancer Research

P1476

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

@en

P2093

Akemi Irie

http://www.w3.org/2001/XMLSchema#string

Akira Yamauchi

http://www.w3.org/2001/XMLSchema#string

Dage Liu

http://www.w3.org/2001/XMLSchema#string

Hiroyasu Yokomise

http://www.w3.org/2001/XMLSchema#string

Keiichi Kontani

http://www.w3.org/2001/XMLSchema#string

Masako Seki

http://www.w3.org/2001/XMLSchema#string

Minoru Kihara

http://www.w3.org/2001/XMLSchema#string

Mitsuomi Hirashima

http://www.w3.org/2001/XMLSchema#string

Nozomu Nishi

http://www.w3.org/2001/XMLSchema#string

Takanori Nakamura

http://www.w3.org/2001/XMLSchema#string

P304

2962-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4172837

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-04-0861

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15837748

http://www.w3.org/2001/XMLSchema#string